Soo Yeon An

Dr. Soo Yeon An


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
SASoo Yeon An
Soo Yeon An
WHWonmook Hwang
Wonmook Hwang
BSByung Joo Sun
Byung Joo Sun
JPJae-Hyeong Park
Jae-Hyeong Park
An SY, et al. J Cardiovasc Imaging. 2019 Sep;28:e54. https://doi.org/10.4250/jcvi.2020.0034

29 June 2016 in Clinical Cardiology
Verified
Journal Article
Closed access
MKMoo Hyun Kim
Moo Hyun Kim
SCSun Young Choi
Sun Young Choi
SASoo Yeon An
Soo Yeon An
VSVictor Serebruany
Victor Serebruany

1 January 2025 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YBYoungnam Bok
Youngnam Bok
JRJae-Hyung Roh
Jae-Hyung Roh
SASoo Yeon An
Soo Yeon An
SJSeon-Ah Jin
Seon-Ah Jin
JKJun Hyung Kim
Jun Hyung Kim
WCWorking Group on Hypertension Complication
Working Group on Hypertension Complication
Bok Y, et al. J Korean Med Sci. 2025 Apr;40(26):e135. https://doi.org/10.3346/jkms.2025.40.e135

1 April 2026 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
JAJung-Min Ahn
Jung-Min Ahn
SKSant Kumar
Sant Kumar
EKEuihong Ko
Euihong Ko
GMGossadi Mohammed
Gossadi Mohammed
KHKentaro Hayashida
Kentaro Hayashida
SPSeung-Jung Park
Seung-Jung Park
Surgical aortic valve (AV) replacement has been the standard treatment for patients with severe symptomatic degenerative AV stenosis (AS). In recent years, transcatheter AV replacement has emerged as an established alternative in selected patient populations, supported by robust evidence in tricuspid AS. However, there has been limited evaluation of transcatheter AV replacement in bicuspid AV AS. Recently, several observational studies have demonstrated the feasibility and safety of transcatheter AV replacement in bicuspid AV AS, and the use of newer-generation devices has shown encouraging outcomes. However, the incidence of procedural complications such as paravalvular regurgitation, permanent pacemaker implantation, and aortic root injury was more frequent in patients with bicuspid AV AS compared with tricuspid AS. We review the clinical evidence of transcatheter AV replacement for bicuspid AV AS and suggest the appropriate criteria for patient and device selection, implantation techniques, and further management.

1 January 2024 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
PSPil-Sang Song
Pil-Sang Song
SSSeok-Woo Seong
Seok-Woo Seong
JKJi-Yeon Kim
Ji-Yeon Kim
SASoo Yeon An
Soo Yeon An
MKMi Joo Kim
Mi Joo Kim
YSYoung Bin Song
Young Bin Song
Song PS, et al. Korean Circ J. 2024 Apr;54(4):189-200. https://doi.org/10.4070/kcj.2023.0268

13 August 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
SASoo Yeon An
Soo Yeon An
MSMan-Shik Shim
Man-Shik Shim
Cardiac angiosarcoma is a rare, malignant neoplasm affecting the heart. We present the clinical history of a 40-year-old patient diagnosed with metastatic angiosarcoma of the heart. The patient complained of shortness of breath, and a cardiac computed tomography scan revealed a mass in the right atrium and pericardial effusion. Transthoracic and transesophageal echocardiography provided detailed anatomical and functional information, and cardiac magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography/computed tomography were used to assess distant metastasis and characterize the mass in detail. Early differential diagnosis and comprehensive evaluation of a cardiac mass are vital for determining appropriate treatment strategies to improve patient outcomes. The pathological results from the endocardial biopsy confirmed the diagnosis of primary angiosarcoma. The patient underwent surgical resection of the right atrial mass but died within one month because of the locally advanced nature of the angiosarcoma and its rapid progression. The patient’s medical journey sheds light on the challenges associated with diagnosing and treating this rare condition, particularly the rapid progression of its cardiac manifestations.